StreetAccount Summary - Trading higher/lower: EU mid-morning
StreetAccount Summary - European pre-market trading update
Redcare Pharmacy preliminary Q2 earnings: Total revenue growth of 15% to 17% vs prior guidance 13% to 15%. Raises its full-year 2026 guidance (€50.70, +1.88)
STOXX annonce des changements dans le DAX, le MDAX, le SDAX et le TecDAX ; les nouveaux ajustements d’indices entreront en vigueur le 22-juin-26
STOXX announces changes in DAX, MDAX, SDAX and TecDAX; new index adjustments will become effective on 22-Jun-26
Transcript Intelligence: Redcare Pharmacy Q1 Earnings Guidance
Transcript Intelligence: Redcare Pharmacy Q1 Earnings Themes
Transcript Intelligence: Redcare Pharmacy Q1 Earnings Q&A
Powered by FactSet Research Systems Inc.